Unaltered striatal dopamine release levels in young Parkin knockout, Pink1 knockout, DJ-1 knockout and LRRK2 R1441G transgenic mice

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sanchez, Gonzalo ^a   Varaschin, Rafael K ^a   Büeler, Hansruedi ^b   Marcogliese, Paul C ^c   Park, David S ^c   Trudeau, Louis Eric ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; DOPAMINE; LEUCINE RICH REPEAT KINASE 2; MEMBRANE PROTEIN; PARKIN; PROTEIN PINK1; UNCLASSIFIED DRUG; DJ-1 PROTEIN, MOUSE; LRRK2 PROTEIN, MOUSE; ONCOPROTEIN; PEROXIREDOXIN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PTEN-INDUCED PUTATIVE KINASE; UBIQUITIN PROTEIN LIGASE;

ACTION POTENTIAL; AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL SURVIVAL; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MALE; MOUSE; MOUSE STRAIN; NERVE CELL NECROSIS; NERVE FUNCTION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; STRAIN DIFFERENCE; TRANSGENIC MOUSE; ANIMAL; DEFICIENCY; ELECTROCHEMICAL ANALYSIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUTATION; NEOSTRIATUM; SYNAPTIC TRANSMISSION;

ANIMALS; DOPAMINE; ELECTROCHEMICAL TECHNIQUES; MALE; MICE, KNOCKOUT; MUTATION; NEOSTRIATUM; ONCOGENE PROTEINS; PEROXIREDOXINS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SYNAPTIC TRANSMISSION; UBIQUITIN-PROTEIN LIGASES;

EID: 84899630517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094826     Document Type: Article

References (52)

1. Hornykiewicz O (2008) Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis 5: 114-117.
2. Surmeier DJ, Guzman JN, Sanchez J, Schumacker PT (2012) Physiological phenotype and vulnerability in Parkinson's disease. Cold Spring Harb Perspect Med 2: a009290.
3. Dawson TM, Ko HS, Dawson VL (2010) Genetic animal models of Parkinson's disease. Neuron 66: 646-661.
4. Saxena S, Caroni P (2011) Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71: 35-48.
5. Cannon JR, Greenamyre JT (2013) Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models. Neurobiol Dis 57: 38-46.
6. Exner N, Lutz AK, Haass C, Winklhofer KF (2012) Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J 31: 3038-3062.
7. Picconi B, Piccoli G, Calabresi P (2012) Synaptic dysfunction in Parkinson's disease. Adv Exp Med Biol 970: 553-572.
8. Subramaniam SR, Chesselet M-F (2013) Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog Neurobiol 106-107: 17-32.
9. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278: 43628-43635.
10. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, et al. (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S 102: 5215-5220.
11. Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, et al. (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S 104: 11441-11446.
12. Kitada T, Pisani A, Karouani M, Haburcak M, Martella G, et al. (2009) Impaired dopamine release and synaptic plasticity in the striatum of parkin-/-mice. J Neurochem 110: 613-621.
13. Kitada T, Tong Y, Gautier CA, Shen J (2009) Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J Neurochem 111: 696-702.
14. Oyama G, Yoshimi K, Natori S, Chikaoka Y, Ren Y-R, et al. (2010) Impaired in vivo dopamine release in parkin knockout mice. Brain Res 1352: 214-222. d
15. Akundi RS, Huang Z, Eason J, Pandya JD, Zhi L, et al. (2011) Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PloS One 6: e16038.
16. Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, et al. (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci Off J Soc Neurosci 30: 1788-1797.
17. Lu X-H, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, et al. (2009) Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci Off J Soc Neurosci 29: 1962-1976.
18. Chesselet M-F, Richter F, Zhu C, Magen I, Watson MB, et al. (2012) A progressive mouse model of Parkinson's disease: the Thy1-aSyn (''Line 61'') mice. Neurother J Am Soc Exp Neurother 9: 297-314.
19. Watson MB, Richter F, Lee SK, Gabby L, Wu J, et al. (2012) Regionally-specific microglial activation in young mice over-expressing human wildtype alphasynuclein. Exp Neurol 237: 318-334.
20. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166.
21. Cui M, Tang X, Christian WV, Yoon Y, Tieu K (2010) Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 285: 11740-11752.
22. Irrcher I, Aleyasin H, Seifert EL, Hewitt SJ, Chhabra S, et al. (2010) Loss of the Parkinson's Disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet. 19: 3734-3746.
23. Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, et al. (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189: 211-221.
24. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S 107: 378-383.
25. Narendra DP, Jin SM, Tanaka A, Suen D-F, Gautier CA, et al. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298.
26. Chen Y, Dorn GW 2nd (2013) PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340: 471-475.
27. Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, et al. (2013) The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci U S A 110: 6400-6405.
28. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33: 627-638.
29. Wang H-L, Chou A-H, Wu A-S, Chen S-Y, Weng Y-H, et al. (2011) PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons. Biochim Biophys Acta 1812: 674-684.
30. Heeman B, Van den Haute C, Aelvoet S-A, Valsecchi F, Rodenburg RJ, et al. (2011) Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J Cell Sci 124: 1115-1125.
31. Hinkle KM, Yue M, Behrouz B, Dächsel JC, Lincoln SJ, et al. (2012) LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors. Mol Neurodegener 7: 25.
32. Melrose HL, Dä chsel JC, Behrouz B, Lincoln SJ, Yue M, et al. (2010) Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 40: 503-517.
33. Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, et al. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45: 489-496.
34. Li Y, Liu W, Oo TF, Wang L, Tang Y, et al. (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 12: 826-828.
35. Paterna JC, Leng A, Weber E, Feldon J, Bueler H (2007) DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther J Am Soc Gene Ther 15: 698-704.
36. Manning-Bog AB, Caudle WM, Perez XA, Reaney SH, Paletzki R, et al. (2007) Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol Dis 27: 141-150.
37. Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, et al. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S 105: 1716-1721.
38. Tong Y, Pisani A, Martella G, Karouani M, Yamaguchi H, et al. (2009) R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci U S A 106: 14622-14627.
39. Rousseaux MWC, Marcogliese PC, Qu D, Hewitt SJ, Seang S, et al. (2012) Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease. Proc Natl Acad Sci U S A 109: 15918-15923.
40. Harris JJ, Jolivet R, Attwell D (2012) Synaptic energy use and supply. Neuron 75: 762-777.
41. Court FA, Coleman MP (2012) Mitochondria as a central sensor for axonal degenerative stimuli. Trends Neurosci 35: 364-372.
42. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, et al. (1999) Plaqueindependent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96: 3228-3233.
43. Platt NJ, Gispert S, Auburger G, Cragg SJ (2012) Striatal dopamine transmission is subtly modified in human A53Ta-synuclein overexpressing mice. PloS One 7: e36397.
44. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12: 2277-2291.
45. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates. 5th ed. San Diego: Academic Press.
46. Martel P, Leo D, Fulton S, Berard M, Trudeau LE (2011) Role of kv1 potassium channels in regulating dopamine release and presynaptic d2 receptor function. PLoS One 6: e20402.
47. Yorgason JT, Espana RA, Jones SR (2011) Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164.
48. Marder E (2011) Variability, compensation, and modulation in neurons and circuits. Proc Natl Acad Sci U S A 108 Suppl 3: 15542-15548.
49. Golden JP, Demaro JA 3rd, Knoten A, Hoshi M, Pehek E, et al. (2013) Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons. J Neurosci Off J Soc Neurosci 33: 17095-17107.
50. Platt NJ, Gispert S, Auburger G, Cragg SJ (2012) Striatal dopamine transmission is subtly modified in human A53Ta-synuclein overexpressing mice. PloS One 7: e36397.
51. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
52. Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, et al. (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A 110: 4016-4025.